Santiago
Moreno Guillén
Catedrático/a de Universidad
Medical Research Council
Londres, Reino UnidoPublications en collaboration avec des chercheurs de Medical Research Council (5)
2017
-
HIV-1 infection in persons homozygous for CCR5-Δ32 allele: The next case and the review
AIDS Reviews, Vol. 19, Núm. 4, pp. 219-230
2016
-
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 4, pp. 1056-1062
2015
-
Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4 + T-cell recovery once HIV-1 suppression is achieved?
AIDS, Vol. 29, Núm. 17, pp. 2323-2333
2014
-
Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
AIDS, Vol. 28, Núm. 16, pp. 2461-2473
2011
-
When to initiate combined antiretroviral therapy to reduce mortality and aids-defining illness in HIV-infected persons in developed countries
Annals of Internal Medicine, Vol. 154, Núm. 8, pp. 509-515